Canexia’s precision cancer solutions digitize biologic samples and make high-quality genomic information accessible and affordable.
Our targeted assays are cost-effective, rapidly scalable, and available for tissue or blood samples. Our Clinical Services team can help you safely optimize and validate NGS profiling within your own laboratory—library preparation, sequencing, report issuing, and sign-off take place at your location.
Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.
Canexia Health’s Find It & Fusions panels detect mutations and gene fusion events in solid tumor tissue. Tissue profiling can be used to help inform treatment decisions or predict progression of cancer based on somatic mutations found in the tumor.
Our comprehensive, secure, informatics and reporting platform delivers automated detailed results, therapeutic recommendations, and expertly curated clinical trials. Our platform, your insights for more informed treatment decisions.
Access Canexia Health’s full stack of bioinformatics, reporting, and quality assurance tools, right from the cloud.
Through our partnerships, we are providing a global blueprint for increased access to molecular cancer care.
Contact us to learn more about our assays, informatics, or support, and learn more about becoming a Canexia Health partner.
In this presentation, Dr. Gregory Tranah, of Sutter Health, discusses opportunities and challenges that bringing in-house testing to a large, complex, health system presents. Dr. Tranah will discuss critical success factors for others who are considering embarking on this path.